MORRIS PLAINS, N.J.--(BUSINESS WIRE)--Xybion Corporation announced today that Pfizer Inc. (NYSE:PFE) has
selected Xybion’s Pristima Suite to manage its global Drug Safety R&D
(DSRD) data management operations. Pristima, a complete off-the-shelf
turn-key solution, is a Software as a Service (SaaS) model that
consolidates several systems and applications into a single, global
solution.

Under the terms of the agreement, Pfizer will implement a suite of
Pristima modules for DSRD data management and reporting of toxicology
studies. Licensed modules include the Pristima SEND module to support
CDISC regulatory electronic data submission and Pristima Savante™ to
aggregate, analyze and visualize data from a central data repository
(CDR).

As a large component of the project, Xybion will provide a number of
services for Pfizer’s implementation of Pristima, including the
utilization of Xybion’s services to facilitate Pristima validation.
Pfizer may also leverage Xybion’s training and implementation services
to train personnel and configure Pristima to meet Pfizer’s best
practices and reporting specifications.

Dr. Pradip Banerjee, CEO at Xybion stated, “Xybion is delighted to
welcome Pfizer to our client community and we are energized and excited
to deliver on this global project. We recognize that Pfizer was a
significant contributor to the requirements and conceptualization of
Pristima, so it is extremely satisfying to see Pfizer has selected
Pristima for its DSRD data management operations.”

Xybion's combination of software, business process management, services,
validation and staffing enables us to cover a broad spectrum of critical
business needs for companies and we deliver our solutions on global
scale. Our leadership in this dynamic and ever-changing industry has
been a cornerstone of our high-value reputation. To learn more, please
visit www.xybion.com.